Rising chronic kidney disease prevalence and morbidity rates in 2023 make CKD the ninth leading cause of death globally, ...
In an analysis of a French cohort of patients with CKD not receiving erythropoiesis stimulating agents, anaemia is more ...
Standard treatments to reduce cardiovascular risk, including mineralocorticoid receptor antagonists, have not lowered the high cardiovascular mortality and morbidity of patients on long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback